A new tool to predict infection in newborns
Part of Genetic & congenital, Infections, Women’s health & pregnancy clinical trials.
This study tests a simple non-invasive score that uses blood flow in muscles to predict if a newborn has or will develop high inflammation levels (C-reactive protein). It may help doctors start treatment earlier in babies with breathing problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must weigh at least 2000 grams (about 4.4 pounds) at birth.
- Your baby must show signs of breathing difficulty, such as fast breathing, grunting, or needing extra oxygen.
- Your baby must be less than 6 hours old.
- Doctors must have decided to provide full life support for your baby.
- You must give written permission (informed consent) within 6 hours of birth.
- Your baby must not have a very low umbilical cord blood pH (below 7.20) or severe birth defects.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a light-based sensor placed on the skin to measure oxygen levels in the gut area of preterm babies during a blood transfusion. It aims to see if this method can safely monitor how well your baby is tolerating the transfusion.
This study looks at early signs of infection in premature babies. It checks two substances in the baby's blood (IL-6 and PCT) within the first 12 hours after birth to see if they can help detect sepsis early. Participation involves collecting a small extra blood sample during routine tests.
This study looks at how well oxygen is being used by the body in newborns who are having breathing problems, from birth through the first hours of life. It also studies whether infection plays a role, which may help doctors better understand and treat newborn breathing trouble.
This study checks whether a new sensor placed on a premature baby’s belly can measure oxygen levels reliably in real time. The goal is to improve how clinicians monitor breathing and oxygen in babies born early.
This study tests a new way to reduce the number of times a preemie baby stops breathing (apnea). It's for babies born early who have apnea but are not on a breathing machine.
This study tests a special, non-invasive sensor (near-infrared light) to help doctors choose the best cooling treatment for some newborns after brain injury. It may improve how well cooling works and how safely it’s managed in the first week of life.
Hear when a new NIRS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.